The Journal of Headache and Pain is a peer-reviewed open access journal specifically dedicated to researchers involved in all aspects of headache and related pain syndromes, including epidemiology, public health, basic science, translational medicine, clinical trials and real-world data. With a multidisciplinary perspective, The Journal of Headache and Pain covers headache medicine and related pain syndromes in all medical disciplines and particularly encourages clinical, translational and basic science submissions in the areas of pain management, genetics, neurology and internal medicine. Read more.
Aims and scope
Click here to see the article collections and thematic series that the journal has published in recent years.
Click here to see Q&As with the authors of the journal's most highly viewed articles!
Click here to view which articles were talked about the most in 2020!
Editorial | 21 February 2018
Migraine is first cause of disability in under 50s: will health politicians now take notice?
Timothy J. Steiner, Lars J. Stovner, Theo Vos, R. Jensen and Z. Katsarava
Consensus article | 16 January 2019
European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
Simona Sacco, Lars Bendtsen, Messoud Ashina, Uwe Reuter, Gisela Terwindt, Dimos-Dimitrios Mitsikostas and Paolo Martelletti
Research | 05 February 2018
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
Andrew M. Blumenfeld, Richard J. Stark, Marshall C. Freeman, Amelia Orejudos and Aubrey Manack Adams
Research | 01 February 2018
Poor medical care for people with migraine in Europe – evidence from the Eurolight study
Zaza Katsarava, Maka Mania, Christian Lampl, Johanna Herberhold and Timothy J. Steiner
Research | 24 May 2018
Patterns of medicinal cannabis use, strain analysis, and substitution effect among patients with migraine, headache, arthritis, and chronic pain in a medicinal cannabis cohort
Eric P. Baron, Philippe Lucas, Joshua Eades and Olivia Hogue
Research | 27 November 2018
My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed
Paolo Martelletti, Todd J. Schwedt, Michel Lanteri-Minet, Rebeca Quintana, Veruska Carboni, Hans-Christoph Diener, Elena Ruiz de la Torre , Audrey Craven, Annette Vangaa Rasmussen, Simon Evans, Annik K. Laflamme, Rachel Fink, Donna Walsh, Paula Dumas & Pamela Vo
Consensus article | 08 October 2018
European Headache Federation guideline on idiopathic intracranial hypertension
Jan Hoffmann, Susan P Mollan, Koen Paemeleire, Christian Lampl, Rigmor H Jensen and Alexandra J Sinclair
Consensus article | 21 May 2019
Aids to management of headache disorders in primary care (2nd edition
T. J. Steiner, R. Jensen, Z. Katsarava, M. Linde, E. A. MacGregor, V. Osipova, K. Paemeleire, J. Olesen, M. Peters & P. Martelletti
Research article | 10 September 2018
Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom
Pamela Vo, Juanzhi Fang, Aikaterini Bilitou, Annik K. Laflamme & Shaloo Gupta
Consensus article | 26 September 2018
Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
Lars Bendtsen, Simona Sacco, Messoud Ashina, Dimos Mitsikostas, Fayyaz Ahmed, Patricia Pozo-Rosich & Paolo Martelletti
Source: Web of Science, data collected: July 2021
European Headache Federation School of Advanced Studies
The European Headache Federation School of Advanced Studies (EHF-SAS) aims to support headache science and offers young EU scientists high quality educational activities to enhance their critical spirit and skills to face headache medicine from a multidisciplinary perspective.
The EHF-SAS covers the richness and diversity of headache medicine fields, including basic science, clinical science, and diagnostic science, and places an emphasis on collaborative projects. The European Headache Federation will support its fellows’ activities allowing them to independently build their own plan sided by the EHF-SAS Scientific Committee.
Editor in Chief (Founding)
Paolo Martelletti, MD,
Department of Clinical and Molecular Medicine
Sapienza University of Rome
Via di Grottarossa 1035
I-00189 Rome, Italy
Assistant to the Editor: Valerio De Angelis
Editorial Board Spotlight
Dr Claudio Tana is an internist at SS Annunziata Hospital of Chieti (Italy). He graduated in Internal Medicine at Chieti University “G. D’Annunzio”. He published more than 100 articles in the internal medicine field, headache disorders, pain and rare diseases.
His main research areas are rare disorders, headache and ultrasound. He is currently involved in the clinical and research fight against COVID-19.
Call for papers
Academic education in headache
The demand for a broad, complete and independent education in Headache Disorders has increased over time. The following international Masters courses guarantee a full coverage of this area of clinical medicine.
Annual Journal Metrics
31 days to first decision for reviewed manuscripts only
17 days to first decision for all manuscripts
68 days from submission to acceptance
13 days from acceptance to publication
7.277 - 2-year Impact Factor
6.067 - 5-year Impact Factor
1.854 - Source Normalized Impact per Paper (SNIP)
1.559 - SCImago Journal Rank (SJR)
1418 Altmetric mentions
- ISSN: 1129-2377 (electronic)
- ISSN: 1129-2369 (print)
- Monoclonal Antibodies in Headache
- Neurophysiology of the Migraine Brain
- Societal Impact of Headache
- Neuromodulation in Headache and Facial Pain Management
- Cluster Headache and other Trigeminal Autonomic Cephalgias
- Peripheral Interventional Management in Headache
- Placebos and Nocebos in Headaches
- Gender and Migraine
- Headache and Comorbidities in Childhood and Adolescence
- Comorbidities in Headache Disorders
- Pharmacological Management of Headaches
- Pathophysiology of Headaches